Sector dividends NovoCure Limited
Equities
NVCR
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.85 USD | -1.92% | -7.39% | -9.85% |
Dec. 02 | HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating | MT |
Dec. 02 | NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint | MT |
Yield (Y) | Yield (Y) | P/E ratio (Y) | Price to Book | EV / Sales | EV / EBITDA | EV / EBIT | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
-.--% | -.--% | 576.17x | 8.468 | 7.7x | 59.35x | 68.65x | 9.48B | ||
+1.72% | +1.85% | 16.49x | 2.602 | - | - | - | 4.67B | ||
-.--% | -.--% | -66.85x | 10.34 | 7.59x | -118.86x | -80.94x | 4.64B | ||
+2.37% | +2.74% | 24.87x | 1.635 | 1.78x | 10.46x | 15.6x | 4.52B | ||
+0.55% | +0.72% | 46.78x | 13.92 | - | - | - | 4.46B | ||
+0.95% | +1.08% | 35.11x | 4.223 | 5.48x | 17.97x | 23.95x | 4.35B | ||
+0.51% | +0.94% | 42.78x | 2.327 | - | - | - | 1.27B | ||
+0.72% | +0.78% | 50.38x | 13.47 | 17.78x | 34.44x | 37.92x | 1.22B | ||
-.--% | -.--% | -9.02x | 1.920 | 433.29x | -37.22x | -36.61x | 969M | ||
-.--% | -.--% | -20.71x | 4.099 | 3.48x | -95.08x | -15.56x | 681M | ||
-.--% | -.--% | -9.02x | 4.443 | 2.34x | -37.18x | -8.39x | 521M | ||
Average | +0.62% | +0.74% | 62.45x | 6.13 | 59.93x | -20.76x | 0.58x | 3.34B | |
Weighted average by Cap. | +0.73% | +0.84% | 157.38x | 6.92 | 22.18x | 2.18x | 16.87x |
- Stock Market
- Equities
- NVCR Stock
- Sector NovoCure Limited
- Sector dividends